Latest AI and machine learning research in prescriptions for healthcare professionals.
INTRODUCTION: The pharmacological treatment of Major Depressive Disorder (MDD) relies on a trial-and-error approach. We introduce an artificial intelligence (AI) model aiming to personalize treatment and improve outcomes, which was deployed in the Artificial Intelligence in Depression Medication Enhancement (AIDME) Study. OBJECTIVES: 1) Develop a model capable of predicting probabilities of remi...
Image-text matching (ITM) is a fundamental problem in computer vision. The key issue lies in jointly learning the visual and textual representation to estimate their similarity accurately. Most existing methods focus on feature enhancement within modality or feature interaction across modalities, which, however, neglects the contextual information of the object representation based on the inter-...
This study investigates the utility of speech signals for AI-based depression screening across varied interaction scenarios, including psychiatric i...
UNLABELLED: Standard-of-care treatment regimens have long been designed for maximal cell killing, yet these strategies often fail when applied to meta...
Predicting drug-target interaction (DTI) is critical in the drug discovery process. Despite remarkable advances in recent DTI models through the int...
Product search is uniquely different from search for documents, Internet resources or vacancies, therefore it requires the development of specialize...
With built-in eye-tracking cameras, the recently released Apple Vision Pro (AVP) mixed reality (MR) headset features gaze-based interaction, eye ima...
Breast cancer is the most prevalent type of cancer among women. The effectiveness of anticancer pharmacological therapy may get adversely affected by...
Clinical variant classification of pathogenic versus benign genetic variants remains a challenge in clinical genetics. Recently, the proposition of ...
Motivation: Unanticipated drug-drug interactions (DDIs) pose significant risks in polypharmacy, emphasizing the need for predictive methods. Recent ...
Existing works based on molecular knowledge neglect the 3D geometric structure of molecules and fail to learn the high-dimensional information of me...
PURPOSE: Recommendations to improve therapeutics are proposals made by pharmacists during the prescription review process to address suboptimal use of...
The inherent heterogeneity of cancer contributes to highly variable responses to any anticancer treatments. This underscores the need to first identif...
RepurposeDrugs (https://repurposedrugs.org/) is a comprehensive web-portal that combines a unique drug indication database with a machine learning (ML...
Accurate prediction of protein-ligand binding affinity (PLA) is important for drug discovery. Recent advances in applying graph neural networks have s...
Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in ...
OBJECTIVE: Current Clinical Decision Support Systems (CDSSs) generate medication alerts that are of limited clinical value, causing alert fatigue. Art...
The precise identification of drug-protein inter action (DPI) can significantly speed up the drug discovery process. Bioassay methods are time-consumi...
Precise and personalized drug application is crucial in the clinical treatment of complex diseases. Although neural networks offer a new approach to i...
This new editorial discusses the promise and challenges of successful integration of natural language processing methods into electronic health record...